Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

cybin inc.

POPULAR ARTICLES

HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq

HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq

Cybin Initiates At-The-Market Equity Program of up to US$100 Million

Cybin Initiates At-The-Market Equity Program of up to US$100 Million

Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq

Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq

LATEST ARTICLES

Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Cybin to Participate in the Jefferies Global Healthcare Conference in London

Cybin to Participate in the Jefferies Global Healthcare Conference in London

Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025

Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025

Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Cybin to Participate at the 2025 Milken Institute Future of Health Summit

Cybin to Participate at the 2025 Milken Institute Future of Health Summit

Cybin Announces Closing of $175 Million Registered Direct Offering

Cybin Announces Closing of $175 Million Registered Direct Offering

Cybin Announces $175 Million Registered Direct Offering

Cybin Announces $175 Million Registered Direct Offering

Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones

Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones

Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder

Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder

Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Cybin to Participate in the Cantor Global Healthcare Conference 2025

Cybin to Participate in the Cantor Global Healthcare Conference 2025

Latest News

Placement Update

Aurum hits 1.7m @ 70.35 g/t gold from 276.5m at BDT2

Construction contract signed for Collie Micronising Facility

MHM appoints R.W. Corkery for EIS readiness

Premier American Uranium Reports Results Following Annual General and Special Meeting of Shareholders

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Gemdale Gold

Gemdale Gold (GEMG:CC)

GEMG:CC

Premier American Uranium

Premier American Uranium (PUR:CC)

PUR:CC

VanadiumCorp Resource

VanadiumCorp Resource (VRB:CC)

VRB:CC

GoldInxs Mining

GoldInxs Mining (INXS:CC)

INXS:CC

Finlay Minerals

Finlay Minerals (FYL:CC)

FYL:CC

Coelacanth Energy

Coelacanth Energy (CEI:CC)

CEI:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES